Acute renal failure during atra treatment

Pediatric Hematology and Oncology

Volumn 25, Issue 2, 2008, Pages 115-118

  Yarali, Nese ^a,b   Tavil, Betül ^a   Kara, Abdurrahman ^a   Özkasap, Serdar ^a   Tunç, Bahattin ^a  

^a DR SAMI ULUS CHILDREN S HOSPITAL   (Turkey)

^b NONE   (Turkey)

Author keywords

ATRA; Fluconazole; Kidney

Indexed keywords

AMIKACIN; ANTHRACYCLINE; CEFEPIME; CYTARABINE; ETOPOSIDE; FLUCONAZOLE; IDARUBICIN; MEROPENEM; MITOXANTRONE; RETINOIC ACID; TIOGUANINE;

ACUTE KIDNEY FAILURE; ADOLESCENT; ANAMNESIS; ARTICLE; CASE REPORT; CHROMOSOME ANALYSIS; CLINICAL FEATURE; COMBINATION CHEMOTHERAPY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; FLOW CYTOMETRY; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; KIDNEY FUNCTION TEST; LABORATORY TEST; PHYSICAL EXAMINATION; PNEUMONIA; PROMYELOCYTIC LEUKEMIA; THROMBOCYTE COUNT; TREATMENT OUTCOME;

ADOLESCENT; ANTIFUNGAL AGENTS; ANTINEOPLASTIC AGENTS; FEMALE; FLUCONAZOLE; HUMANS; KIDNEY FAILURE, ACUTE; LEUKEMIA, PROMYELOCYTIC, ACUTE; TRETINOIN;

EID: 41149158636     PISSN: 08880018     EISSN: 15210669     Source Type: Journal    
DOI: 10.1080/08880010801888287     Document Type: Article

References (10)

1. Tallman MS, Andersen JW, Schiffer CA, et al. All-trans retinoic acid in acute promyelocytic leukemia. N Engl J Med. 1997;337:1021-1028.
2. Larson RS, Tallmann MS. Retinoic acid syndrome: manifestations, pathogenesis and treatment. Best Pract Res Clin Hematol. 2003;16:453-461.
3. Avvisati G, Coco FL,Mandelli F. Acute promyelocytic leukemia: clinical andmorphological features and prognostic factors. Semin Hematol. 2001;38:4-12.
4. Fenaux P, Chomienne C, Degos L. All-trans retinoic acid and chemotherapy in the treatment of acute promyelocytic leukemia. Semin Hematol. 2001;38:13-25.
5. Vanier KL, Mattiussi A, Johnston DL. Interaction of all-trans retinoic acid with fluconazole in acute promyelocytic leukemia. J Pediatr Hematol Oncol. 2003;25:403-404.
6. Testi AM, Biondi A, Lo Coco M, et al. GIMEMA-AIEOPAIDA protocol for the treatment of newly diagnosed acute promyelocytic leukemia (APL) in children. Blood. 2005;106:447-453.
7. Bergstein JM. Toxic nephropathies-renal failure. In: Behrman RE, Kliegman RM, Arvin AM, eds. Nelson Textbook of Pediatrics. Philadelphia: Saunders; 1996:1513-1518.
8. Hoitsma AJ, Wetzels JF, Koene RA. Drug-induced nephrotoxicity: aetiology, clinical features and management. Drug Saf. 1991;6:131-147.
9. Schwartz EL, Hallam S, Gallagher RE, Wiernik PH. Inhibition of all-trans retinoic acid metabolism by fluconazole in vitro and in patients with acute promyelocytic leukemia. Biochem Pharmacol. 1995;28:923-928.
10. Menegola E, Broccia ML, Di Renzo F, Massa V, Giavini E. Relationship between hindbrain segmentation, neural crest cell migration and branchial arch abnormalities in rat embryos exposed to fluconazole and retinoic acid in vitro. Rep Toxicol. 2004;18:121-130.